Exploiting cancer vulnerabilities: mTOR, autophagy, and homeostatic imbalance

Area of Science:

• Cellular Biology
• Oncology
• Molecular Medicine

Background:

• Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) is a key regulator of cell growth, nutrient, and energy homeostasis.
• In cancer cells, mTORC1 signaling is often dysregulated, leading to uncontrolled proliferation and increased cellular stress.
• This dysregulation compromises cancer cell adaptability, creating vulnerabilities exploitable for therapeutic intervention.

Purpose of the Study:

• To explore the intricate signaling pathways governing mTORC1 and autophagy.
• To identify cancer-specific vulnerabilities arising from aberrant mTORC1 activation.
• To review current and potential anticancer therapies targeting the mTORC1-autophagy axis.

Main Methods:

• Literature review of signaling pathways involved in mTORC1 and autophagy regulation.
• Analysis of cancer cell adaptation mechanisms under nutrient and energy stress.
• Examination of therapeutic strategies targeting mTORC1 and autophagy in cancer.

Main Results:

• Hyperactivated mTORC1 in cancer cells promotes growth and survival but impairs homeostatic balance.
• mTORC1-mediated regulation of autophagy is crucial for nutrient and energy balance, cell growth, and survival.
• Aberrant mTORC1 signaling creates vulnerabilities in cancer cells, including heightened stress and loss of homeostasis.

Conclusions:

• Dysregulated mTORC1 signaling and its impact on autophagy represent a critical vulnerability in cancer.
• Targeting the mTORC1-autophagy pathway holds significant therapeutic potential for various cancers.
• Further research into these pathways can lead to the development of novel anticancer strategies.